Recall Record

Ann Arbor, MI, United States

NeuMoDx Molecular Inc recalls

6 recalls recorded since 2018, most recently on 24 May 2023. 5 are listed as ongoing. Status and classification are as published by the FDA.

Recalls6
Ongoing (FDA)5
Terminated or completed1
Class I (FDA)0

Ongoing Class II Medical devices

Recall started
24 May 2023
Reason
Top label on some of the NeuMoDx cartridges within these lots may have been incorrectly applied during the manufacturing process, resulting in encroachment into the PCR region. The misplaced label may interfere with the module s optics performance, thereby increasing the risk for false positive results
Distribution
US Nationwide Distribution to states of: Kansas, Florida, Texas, Ohio, New York, Michigan, Pennsylvania; and OUS (Foreign) to countries of: AT, BE, CH, DE, ES, FI, FR, GB, IT, LV, PL, RO, SE
Initiated
Voluntary: Firm initiated
Recall number
Z-2255-2023

Ongoing Class III Medical devices

Recall started
15 May 2023
Reason
Potential for lot number discrepancies between the test strip packaging and the barcode label applied to the test strip that is read by the instrument for LOT 123909 of NeuMoDx SARS-CoV-2 Test Strips (REF 300800). The instrument registers the non-human readable text as lot number 123910 from the barcode label.
Distribution
US Nationwide distribution in the states of FL, MI, NM, NY, TN, TX.
Initiated
Voluntary: Firm initiated
Recall number
Z-2093-2023

Ongoing Class II Medical devices

Recall started
13 May 2022
Reason
There is a potential for reduced analytical sensitivity for samples in the 1x - 3x LOD range for Flu A, RSV, and SARS-CoV-2 targets. This may lead to false negative results, allowing ongoing transmission to others and delaying appropriate treatment.
Distribution
Domestic distribution to FL, NY, MD, PA, VA, MI, TN, NM. Foreign distribution to AT, AU, BE, CH, DE, FI, FR, GB, GR, HK, ID, IT, LT, NL, SA, SE, and SI.
Initiated
Voluntary: Firm initiated
Recall number
Z-1251-2022

Ongoing Class II Medical devices

Recall started
18 February 2022
Reason
Potential for false positive results for SARS-CoV-2 in identified lots of cartridges, when used in conjunction with assays containing SARS-CoV-2 targets (NeuMoDx" SARS-CoV-2 Test Strip Cat #300800 and NeuMoDx" Flu A-B/RSV/SARS-CoV-2 Vantage Assay Cat #300900) result incorrect management of patients
Distribution
Worldwide distribution - US Nationwide distribution in the states of OH, MO, VA, MI, MI, FL, MD, IA, NY, MO and the countries of Italy, Germany, Switzerland, Sweden, Netherlands, Finland, Spain, United Kingdom, Belgium, Austria, Hong Kong, France, Denmark, Slovenia.
Initiated
Voluntary: Firm initiated
Recall number
Z-1000-2022

Ongoing Class II Medical devices

Recall started
21 January 2022
Reason
A risk for product contamination was identified for the affected product lot. If used, there is an increased potential for SARS-CoV-2 false positive results when using the product.
Distribution
US Nationwide distribution in the states of FL, MD, MI, NY.
Initiated
Voluntary: Firm initiated
Recall number
Z-0738-2022

Terminated Class II Medical devices

Recall started
4 May 2021
Terminated
21 June 2022
Reason
There is a potential for false positive results when certain lots of cartridges are used in conjunction with specific assays.
Distribution
Worldwide distribution.
Initiated
Voluntary: Firm initiated
Recall number
Z-1978-2021

A terminated FDA recall means the FDA has determined that all reasonable efforts to remove or correct the product have been made. What statuses mean.